Results 211 to 220 of about 70,369 (254)

Gold nanoparticles in pediatric DIPG: promise at the blood-brain barrier's price. [PDF]

Ann Med Surg (Lond)
Zahid M, Ahmed A, Shah SA, Talha M, Fatima M.   +4 more
europepmc   +1 more source

Efficacy and safety of tumor-treating fields combined with concurrent chemoradiotherapy for newly diagnosed glioblastoma patients. [PDF]

Medicine (Baltimore)
Wang Z, Jiang Z, Zong D, Zhu H, Zou G, Xu J, Guo W, Ge Y, Wang X, Yu J, He X.   +10 more
europepmc   +1 more source

Venous Thromboembolism and Bleeding with Temozolomide-, Bevacizumab-, and Nitrosourea-Based Therapy in Glioma: A Dual-Database Pharmacovigilance Study. [PDF]

Cancers (Basel)
Hou X, Zhang Y, Liang C, Yao S.
europepmc   +1 more source

Temozolomide in aggressive and metastatic pituitary tumors: a Brazilian multicenter real-world cohort study. [PDF]

Pituitary
de Magalhães IPA, de Macedo CRPB, Naves LA, Czepielewski MA, Rosa IN, de Santana LB, de Almeida TS, Padula M, Elias PCL, de Castro M, Kasuki L, Gadelha MR, Rech CGSL, Garmes HM, Boguszewski CL, Jallad RS, Nakaguma M, Fragoso MCBV, Machado MC, Glezer A, da Cunha Neto MBC, Feher O, Batista RL.   +22 more
europepmc   +1 more source

High-grade glioma with dural progression: A single-center case series and review of literature. [PDF]

Radiol Case Rep
Wang G, Nirappel A, Kaur A, Martin D, Vempati P, Hodges T, Badve C.   +6 more
europepmc   +1 more source

Defying the Odds in Recurrent Glioblastoma: Complete Response following Salvage Therapy with Bevacizumab and Irinotecan - A Case Report. [PDF]

Case Rep Oncol
Yousefi A, Saraee E, Ghalehtaki R.
europepmc   +1 more source

Temozolomide for the Treatment of Metastatic Melanoma

Current Oncology, 2007
Questions: What is the role of single-agent temozolomide in the treatment of patients with metastatic melanoma? In comparison with single-agent temozolomide, does the addition of interferon-α to temozolomide improve disease-free survival, overall ...
T Petrella
exaly   +2 more sources

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas [PDF]

Journal of Neuro-Oncology, 2015
Temozolomide is effective in some patients with progressive pituitary adenoma or carcinoma. We report a survey study of Italian patients treated with Temozolomide because of aggressive pituitary adenoma or carcinoma resistant to standard therapies ...
Marco Losa, Fausto Bogazzi, Salvatore Cannavo   +2 more
exaly   +2 more sources

Skin delivery potency and antitumor activities of temozolomide ester prodrugs

Cancer Letters, 2006
Clinical trials have shown temozolomide to be an effective agent for treatment of malignant melanoma. In order to investigate its suitability for delivery via the skin, a series of temozolomide esters was synthesized as prodrugs.
Barbara R Conway
exaly   +2 more sources